HIV-1-specific T cell-dependent natural killer (NK) cell activation: Major contribution by NK cells to interferon-γ production in response to HIV-1 antigens

AIDS Research and Human Retroviruses

Volumn 25, Issue 6, 2009, Pages 603-605

  Loo, Christopher P ^a   Long, Brian R ^a   Hecht, Frederick M ^a   Nixon, Douglas F ^a   Michaëlsson, Jakob ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; VIRUS ANTIGEN; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN;

ARTICLE; CELL ACTIVATION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERFERON PRODUCTION; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MONONUCLEAR CELL; SECRETION;

CELLS, CULTURED; HIV ANTIGENS; HIV INFECTIONS; HIV-1; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LEUKOCYTES, MONONUCLEAR; T-LYMPHOCYTES;

EID: 67651148089     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0165     Document Type: Article

References (8)

1. Lodoen MB and Lanier LL: Natural killer cells as an initial defense against pathogens. Curr Opin Immunol 2006;18: 391-398.
2. bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: A potential new link between adaptive and innate immunity. Blood 2003;101:3052-3057.
3. He XS, Draghi M, Mahmood K, Holmes TH, Kemble GW, Dekker CL, et al.: T cell-dependent production of IFN-g by NK cells in response to influenza A virus. J Clin Invest 2004; 114:1812-1819.
4. Alter G, Martin MP, Teigen N, Carr WH, Suscovich TJ, Schneidewind A, et al.: Differential natural killer cell-mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J Exp Med 2007;204:3027-3036.
5. + patients produce C-C chemokines and inhibit HIV-1 infection. J Immunol 1998;161:6433-6438.
6. Kottilil S, Chun TW, Moir S, Liu S, McLaughlin M, Hallahan CW, et al.: Innate immunity in human immunodeficiency virus infection: Effect of viremia on natural killer cell function. J Infect Dis 2003;187:1038-1045.
7. Martin MP, Gao X, Lee JH, Nelson GW, Detels R, Goedert JJ, et al.: Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat Genet 2002;31:429-434.
8. Martin MP, Qi Y, Gao X, Yamada E, Martin JN, Pereyra F, et al.: Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat Genet 2007;39:733-740.